Cargando…

Be vigilant in treating a patient with diabetes and COVID-19-associated mucormycosis

Detalles Bibliográficos
Autores principales:	Thangaraju, Pugazhenthan, Velmurugan, Hemasri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521839/ https://www.ncbi.nlm.nih.gov/pubmed/37767436 http://dx.doi.org/10.4103/jfmpc.jfmpc_97_23

Ejemplares similares

Does Remdesivir maintain the race in the general treatment protocol of COVID-19?
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2021)

Diligence needed on treatment of primary multidrug-resistant pulmonary tuberculosis with concomitant COVID-19 infection
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2022)

Gestational diabetes: Unfolded area still a concern
por: Velmurugan, Hemasri, et al.
Publicado: (2023)

Time to be vigilant in contacts of leprosy for possible single-dose rifampicin
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2022)

Health strategy in South State of India – Towards older people
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2023)

Vigilance in selection of low-dose versus high-dose steroids in COVID-19
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2021)

Nightmares and Mirtazapine—Time to be vigilant
por: Sudha TY, Sree, et al.
Publicado: (2020)

Need for vigilance monitoring regarding neurological disorders post-COVID vaccination
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2023)

Paediatric dosage ‘need of hours among family physicians/other speciality physicians’
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2022)

Prerequisite of doing clinical trial with drugs in COVID-19 patients: Situational experience
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

Vigilance in Prescribing Nonsteroidal Anti-inflammatory Drugs
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2017)

Pott’s puffy tumor in coronavirus disease-2019 associated mucormycosis
por: Arora, Ripu Daman, et al.
Publicado: (2022)

Violence against doctor – few points to be focussed
por: Thangaraju, Pugazhenthan
Publicado: (2020)

COVID-19-Associated Mucormycosis in Diabetic Patients: The Tip of an Iceberg
por: Parsaei, Amirhossein, et al.
Publicado: (2022)

Current treatment guideline by the World Health Organization against leprosy: A positive focus
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Responding to the Global Guidelines for the Prevention of Surgical Site Infection, 2018: A focus on surgical antibiotic prophylaxis prolongation
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Leprosy cases with respiratory infection – Rule out tuberculosis simultaneously with dapsone syndrome
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2018)

Monotherapy with liraglutide – Points to be focussed
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Clofazimine induced methemoglobinemia – Points to be focussed
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Medical residents: Research and publication priorities/confusions
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

Government of India initiative against leprosy—We should be aware
por: Venkatesan, Sajitha, et al.
Publicado: (2019)

Named terminologies of patient-centered – A focus respective to stigmatized disease
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

Triple challenge of diabetes, COVID-19, and mucormycosis
por: Rastogi, Ashu, et al.
Publicado: (2021)

Palliative oral care for COVID-19 associated oral mucormycosis in diabetic patients
por: Rathee, Manu, et al.
Publicado: (2022)

Chloroquine induced utricaria—A detailed history helps
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Low-dose oxytocin - a safe strategy in postpartum hemorrhage
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Curcumin and fungal infection – commonly available herbs for common female infection
por: Varthya, Shoban Babu, et al.
Publicado: (2020)

Fixed-dose combinations: An essential for rational preparation
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2021)

COVID-19 and orbital mucormycosis
por: Sarkar, Sandip, et al.
Publicado: (2021)

COVID-19 associated mucormycosis - a recent challenge
por: dos Santos, Vitorino Modesto, et al.
Publicado: (2023)

Final Leprosy Push: Out of Society
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2018)

Leprosy - the current target in national programmes
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

Mucormycosis in COVID-19: The Indian scenario
por: Ghosh, Ritwik, et al.
Publicado: (2022)

Concurrent plexiform ameloblastoma and COVID-19-associated mucormycosis of the maxilla
por: Ingle, Yashwant, et al.
Publicado: (2022)

Mucormycosis: A killer in the shadow of COVID-19
por: Suvvari, Tarun Kumar, et al.
Publicado: (2021)

Additional insights on COVID-associated mucormycosis
por: Panta, Prashanth
Publicado: (2022)

A review and case report of enigmatic superficial endometrial spread of cancer of the uterine cervix: Need for vigilance in the primary care setting
por: Bagde, Madhuri N., et al.
Publicado: (2021)

Cephalosporin's induced hepatic enzyme derangement - An educational report
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

COVID-19 associated mucormycosis (CAM): A tale of two pathogens
por: Pustake, Manas, et al.
Publicado: (2021)

Prevention of mucormycosis in COVID-19 – the need of the hour
por: Ish, Pranav, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7smuvg84qqkg773ar6vk7nib9p